Literature DB >> 17916547

Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index.

Chen-Hua Liu1, Shih-Jer Hsu, Jou-Wei Lin, Juey-Jen Hwang, Chun-Jen Liu, Pei-Ming Yang, Ming-Yang Lai, Pei-Jer Chen, Jun-Herng Chen, Jia-Horng Kao, Ding-Shinn Chen.   

Abstract

BACKGROUND & AIMS: The value of Doppler ultrasonography to evaluate the severity of hepatic fibrosis in patients with chronic hepatitis C (CHC) remains controversial.
METHODS: Consecutive histologically proven patients with CHC over a 4-year period were divided into training (n = 335) and validation (n = 168) sets. Hepatic Doppler impedance index, splenic Doppler impedance index, and mean portal vein velocity were evaluated for all patients before liver biopsies. Multivariate logistic regression was performed to find the independent factors to predict patients with significant fibrosis (>/=F2) and cirrhosis (F4) in the training set. Receiver operating characteristic curves were constructed for these factors to evaluate the diagnostic accuracy of significant hepatic fibrosis and cirrhosis in the training set, and in the validation set to evaluate the reproducibility.
RESULTS: Multivariate logistic regression revealed that the splenic arterial pulsatility index (SAPI) and the mean portal vein velocity were predictive of significant fibrosis (>/=F2) and cirrhosis (F4). Receiver operating characteristic analysis showed the areas under the curves of regression models and SAPI were comparable in predicting significant fibrosis (0.88 vs 0.87, P = .22) and cirrhosis (0.92 vs 0.90, P = .12) in the training set. Areas under the curves of SAPI were 0.89 and 0.92 in predicting significant hepatic fibrosis and cirrhosis in the validation set. By choosing optimized cut-off levels, 54% and 76% of the patients with significant hepatic fibrosis and cirrhosis could be predicted correctly.
CONCLUSIONS: SAPI is accurate and reproducible for assessing the severity of hepatic fibrosis in patients with CHC. Applying this simple Doppler index can decrease the need for staging liver biopsy.

Entities:  

Mesh:

Year:  2007        PMID: 17916547     DOI: 10.1016/j.cgh.2007.07.017

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  5 in total

Review 1.  Accuracy of ultrasound to identify chronic liver disease.

Authors:  Richard Allan; Kerry Thoirs; Maureen Phillips
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

2.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

3.  External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.

Authors:  Beom Kyung Kim; Kwang Hyub Han; Jun Yong Park; Sang Hoon Ahn; Chae Yoon Chon; Ja Kyung Kim; Yong Han Paik; Kwan Sik Lee; Young Nyun Park; Do Young Kim
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

4.  Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease.

Authors:  Masashi Hirooka; Yohei Koizumi; Teruki Miyake; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Atsushi Yukimoto; Yoshiko Nakamura; Yusuke Imai; Masanori Abe; Yoichi Hiasa
Journal:  Hepatol Commun       Date:  2017-07-27

5.  Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Wei-Yu Kao; I-Wei Chang; Chi-Long Chen; Chien-Wei Su; Sheng Uei Fang; Jui-Hsiang Tang; Chun-Chao Chang; Yu-Jia Chang; Weu Wang
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.